User profiles for Francisco Leyva

Francisco Leyva

Professor of Cardiology
Verified email at uhb.nhs.uk
Cited by 23974

2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization …

…, C Starck, I Thylén, JM Tolosana, F Leyva… - EP …, 2022 - academic.oup.com
for digital applications (smartphones, etc.). These versions are abridged and thus, for more
detailed information, the user should always access to the full text version of the guidelines, …

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …

…, C Leclercq, BS Lewis, F Leyva… - European journal of …, 2022 - Wiley Online Library
… Lewis (Israel), Francisco Leyva (United Kingdom), AleVs Linhart (Czech Republic), Maja‐Lisa
Løchen (Norway), Lars H. Lund (Sweden), Donna Mancini (United States of America), …

Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging

…, W Doehner, M Rauchhaus, R Sharma, D Francis… - Circulation, 2003 - Am Heart Assoc
Background— Serum uric acid (UA) could be a valid prognostic marker and useful for
metabolic, hemodynamic, and functional (MFH) staging in chronic heart failure (CHF). Methods …

Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure

…, C Walton, IF Godsland, AL Clark, F Leyva… - Journal of the American …, 1997 - jacc.org
Objectives. We attempted to assess insulin sensitivity in patients with chronic heart failure (CHF)
and its relation to disease severity. Background. Peripheral muscular changes influence …

The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular …

…, F Wenzelburger, E Lee, G Heatlie, F Leyva… - Journal of the American …, 2009 - jacc.org
Objectives : The purpose of this study was to test the hypothesis that in heart failure with
normal ejection fraction (HFNEF) exercise limitation is due to combined systolic and diastolic …

Uric acid in chronic heart failure: a marker of chronic inflammation

F Leyva, SD Anker, IF Godsland, M Teixeira… - European heart …, 1998 - academic.oup.com
Background Chronic heart failure is associated with hyperuricaemia and elevations in
circulating markers of inflammation. Activation of xanthine oxidase, through free radical release, …

Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk

F Leyva, IF Godsland, M Ghatei… - … , and vascular biology, 1998 - Am Heart Assoc
In humans, production of the adipocyte-derived peptide leptin has been linked to adiposity,
insulin, and insulin sensitivity. We therefore considered that alterations in plasma leptin …

Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis

…, A Barison, P Mckenna, I Mordi, KH Haugaa, F Leyva… - JACC: Heart Failure, 2017 - jacc.org
Objectives : The aim of this study was to evaluate the association between late gadolinium
enhancement (LGE) on cardiac magnetic resonance imaging and ventricular arrhythmias or …

Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure

…, S von Haehling, DO Okonko, F Leyva… - Journal of the American …, 2005 - jacc.org
Objectives : The aim of this study was to determine the significance of insulin resistance as
an independent risk factor for impaired prognosis in patients with chronic heart failure (CHF). …

Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy

F Leyva, RJ Taylor, PWX Foley, F Umar… - Journal of the American …, 2012 - jacc.org
Objectives : The aim of this study was to determine whether left ventricular (LV) midwall
fibrosis, detected by midwall hyperenhancement (MWHE) on late gadolinium enhancement …